Small cell carcinoma of the prostate (SCCP), although relatively rare, is the most aggressive
variant of prostate cancer, currently with no successful treatment. It was therefore tempting to …

Purpose : Urachal carcinoma accounts for less than 1% of all bladder cancers. Limited data
exist on disease related outcomes originating from case reports and select referral centers. …

Purpose : Differentiation between Gleason score 6 and 7 in prostate biopsy is important for
treatment decision making. Nevertheless, under grading errors compared with the actual …

We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined
cytogenetic, array-based comparative genomic hybridization and expression analyses. …

Purpose: Androgen deprivation therapy may increase the risk of cardiovascular disease.
Limited data suggest that GnRH (gonadotropin-releasing hormone) antagonist may be …

CONTEXT: Androgens are vital for growth and maintenance of the prostate; however, the
notion that pathologic prostate growth, benign or malignant, can be stimulated by androgens is …

Radiation therapy is a standard treatment for prostate cancer (PC). The postulated
mechanism of action for radiation therapy is the generation of reactive oxygen species (ROS). …

Purpose To explore how follicle-stimulating hormone (FSH) may contribute to cardiovascular,
metabolic, skeletal, and cognitive events in men treated for prostate cancer, with various …

PURPOSE: Modern PDT for urological tumors is a potentially selective approach in which in
situ photosensitization by a nontoxic drug, locally activated by light, generates cytotoxic …

OBJECTIVES: To examine a possible relationship between plasma adiponectin levels and
renal cell carcinoma (RCC). Adiponectin, a cytokine secreted by adipocytes, is a potent …